Commitments and Contingencies (Details) $ in Thousands						1 Months Ended			2 Months Ended	18 Months Ended
	Feb. 02, 2026 patent	Mar. 08, 2023 USD ($)	Feb. 28, 2022 case	Sep. 11, 2020	Mar. 24, 2015 patent	Jun. 30, 2025 USD ($)	May 31, 2025 USD ($)	Mar. 31, 2022 case stockholder	Mar. 31, 2022 stockholder	Apr. 30, 2017 patent lawsuit
Xtampza ER Litigation
Commitments and Contingencies
Number of patents allegedly infringed | patent					3					2
Stay period before FDA can issue a final approval unless it is terminated					30 months
Number of lawsuits filed | lawsuit										2
Statutory period of proceedings				18 months
Xtampza ER Litigation, District of Massachusetts
Commitments and Contingencies
Number of patents allegedly infringed | patent					3
Stay period before FDA can issue a final approval unless it is terminated					30 months
Aquestive Therapeutics, Inc Litigation | Selling, general and administrative
Commitments and Contingencies
Litigation settlement, amount awarded to other party | $		$ 8,500
Grunenthal GMBG Litigation | Subsequent Event
Commitments and Contingencies
Number of patents allegedly infringed | patent	2
BDSI Acquisition Litigation
Commitments and Contingencies
Number of additional cases filed | case			2					2
Number of demand letters received from purported stockholders | stockholder								4	3
Arbitration with North Sound Pharmaceuticals, Inc | Minimum
Commitments and Contingencies
Damages sought | $							$ 500,000
Walgreen Co. Lawsuit | Minimum
Commitments and Contingencies
Damages sought | $						$ 14,000